NCT06354465View on ClinicalTrials.gov

Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

RecruitingOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions

Opioid Use DisorderCriminal JusticeTreatment Adherence and Compliance

Trial Locations (1)

02920

RECRUITING

Rhode Island Department of Corrections, Cranston

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Lifespan

OTHER